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Introduction: Adulterated cocaine with levamisole in different concentrations has been 
increasingly used during the last decades. Levamisole can cause skin lesions, 
intravascular thrombosis, neutropenia, and crescentic nephritis. Physician awareness is 
essential for ensuring a proper diagnosis, because patients usually deny the use of illicit 
drugs. 
Methods: We describe a series of five patients with anti-neutrophil cytoplasmic 
antibody (ANCA) positive vasculitis induced by levamisole-adulterated cocaine with 
renal and/or skin manifestations, which were prospectively followed at a single hospital. 
Demographics and clinical characteristics are presented. 
Results: Urine toxicology was all positive for cocaine and levamisole, tested by 
immunochromatography and gas chromatography-mass spectrometry. Three patients 
brought a sample of the cocaine powder (1 g), in which the presence of cocaine and 
levamisole was confirmed (levamisole: 32%, 1,2% and 0,5% in each powder). Clinical 
data are presented below. 
 Female, 46y Male, 48y Male, 48y Male, 50y Female, 22y 
Renal 
manifes-
tations 
 
 
 
None 
Creatinine (Cr): 
0,8 mg/dL 
Urine protein/ 
creatinine (UPC): 
0,01 
 
 
 
 
 
 
UPC: 6,6 
Cr: 8,6 mg/dL 
Dialysis dependent  
 
Renal biopsy (R-Bx): 
pauci-immune 
crescentic glomerulo- 
nephritis  
UPC: 0,66 
Cr:  2,7 mg/dL   
 
R-Bx: pauci-immune 
crescentic glomerulo- 
nephritis 
UPC: 0,97 
Cr 4,8 mg/dL  
 
R-Bx: pauci-immune 
crescentic glomerulo- 
nephritis 
 
 
 
 
 
 
UPC: 1,8 
Cr 3,4 mg/dL  
 
R-Bx: pauci-immune 
crescentic glomerulo- 
nephritis 
 
 
 
 
 
 
Skin 
manifes- 
tations 
 
Retiform purpura  
 
Skin biopsy (S-
Bx): leukocyto-
clastic vasculitis  
Retiform purpura  
 
S-Bx: neutrophilic 
vasculitis of small 
vessels 
 
None Retiform purpura  
Focal necrosis in ear 
lobes 
 
S-Bx: leukocyto-clastic 
vasculitis 
Retiform purpura  
 
 
Serology 
markers 
pANCA >1/320  pANCA 1/320 pANCA >1/320 
 
pANCA >1/320 
Anti-MPO and anti-
PR3 positive  
pANCA >1/320 
 
Treat- 
ment 
Oral prednisone  Corticosteroids  
Cyclophospha-mide  
Plasmapheresis  
Corticosteroids  
Cyclophospha-mide  
 
Corticosteroids  
Cyclophospha-mide  
 
Corticosteroids  
Cyclophospha-mide  
 
Outcome Death (sepsis) 
 
ESRD: chronic 
hemodialysis 
No skin lesions 
Cr: 1,2 mg/dL 
 
Cr: 1,5 mg/dL 
No skin lesions 
Cr: 0,9 mg/dL 
 
ANCA: anti-neutrophil cytoplasmic antibody; MPO: myeloperoxidase; PR3: proteinase 
3; ESRD: end-stage kidney disease 
 
Conclusion: Cocaine/levamisole-induced vasculitis should be suspected in patients with 
renal and skin lesions, even when illicit drug use is denied. A urine drug toxicology 
screen is necessary to confirm the diagnosis and must be done during follow-up to 
ascertain drug abstinence. This condition can be associated with poor outcomes, such as 
ESRD and death.  
